Energy metabolism is compromised in skeletal muscle of rats chronically-treated with glutaric acid

Metabolic Brain Disease

Volumn 22, Issue 1, 2007, Pages 111-123

  Ferreira, Gustavo Da C ^a   Schuck, Patrícia F ^a   Viegas, Carolina M ^a   Tonin, Anelise ^a   Latini, Alexandra ^a,b   Dutra Filho, Carlos S ^a   Wyse, Angela T S ^a   Wannmacher, Clóvis M D ^a   Vargas, Carmen R ^a,b   Wajner, Moacir ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

Creatine kinase; Energy metabolism; Glutaric acid; Respiratory chain; Skeletal muscle

Indexed keywords

CREATINE KINASE; GLUTARIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; MALE; METABOLIC DISORDER; NONHUMAN; RAT; RESPIRATORY CHAIN; SKELETAL MUSCLE; WISTAR RAT;

AMINO ACID METABOLISM, INBORN ERRORS; ANIMALS; BRAIN; CARBON DIOXIDE; CARBON RADIOISOTOPES; CREATINE KINASE; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT; ENERGY METABOLISM; FEMALE; GLUTARATES; MALE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; PREGNANCY; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 33847673584     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-006-9043-0     Document Type: Article

References (49)

1. Bjugstad KB, Zawada WM, Goodman S, Free CR (2001) IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J Inherit Metab Dis 24:631-647
2. Brouillet E, Guyot MC, Mittoux V, Altairac S, Conde F, Palfi S, Hantraye P (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794-805
3. da C Ferreira G, Viegas CM, Schuck PF, Latini A, Dutra-Filho CS, Wyse AT, Wannmacher CM, Vargas CR, Wajner M (2005) Glutaric acid moderately compromises energy metabolism in rat brain. Int J Dev Neurosci 23:687-693
4. da Silva CG, Ribeiro CA, Leipnitz G, Dutra-Filho CS, Wyse AT, Wannmacher CM, Sarkis JJ, Jakobs C, Wajner M (2002) Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim Biophys Acta 1586:81-91
5. Das AM, Lucke T, Ullrich K (2003) Glutaric aciduria I: creatine supplementation restores creatine phosphate levels in mixed cortex cells from rat incubated with 3-hydroxyglutarate. Mol Genet Metab 78:108-111
6. de Mello CF, Kölker S, Ahlemeyer B, de Souza FR, Fighera MR, Mayatepek E, Krieglstein J, Hoffmann GF, Wajner M (2001) Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res 916:70-75
7. de Oliveira Marques F, Hagen ME, Pederzolli CD, Sgaravatti AM, Durigon K, Testa CG, Wannmacher CM, de Souza Wyse AT, Wajner M, Dutra-Filho CS (2003) Glutaric acid induces oxidative stress in brain of young rats. Brain Res 964:153-158
8. Ferreira G da C, Viegas CM, Schuck PF, Tonin A, Ribeiro CA, de M Coelho D, Dalla-Costa T, Latini A, Wyse AT, Wannmacher CM, Vargas CR, Wajner M (2005) Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats. Neurochem Res 30:1123-1131
9. Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders M, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23-36
10. Floret D, Divry P, Dingeon N, Monnet P (1979) Acidurie glutarique. Arch FR Pediatr 36:462-470
11. Flott-Rahmel B, Falter C, Schluff P, Fingerhut R, Christensen E, Jakobs C, Musshoff U, Fautek JD, Deufel T, Ludolph A, Ullrich K (1997) Nerve cell lesions caused by 3-hydroxyglutaric acid: A possible mechanism for neurodegeneration in glutaric acidaemia I. J Inherit Metab Dis 20:387-390
12. Freudenberg F, Lukacs Z, Ullrich K (2004) 3-Hydroxyglutaric acid fail to affect the viability of primary neuronal rat cells. Neurobiol Dis 16:581-584
13. Frizzo ME, Schwarzbold C, Porciuncula LO, Dalcin KB, Rosa RB, Ribeiro CA, Souza DO, Wajner M (2004) 3-hydroxyglutaric acid enhances glutamate uptake into astrocytes from cerebral cortex of young rats. Neurochem Int 44:345-353
14. Goodman SI, Frerman FE (2001) Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited diseas, 8th edn. McGraw-Hill, New York, pp 2195-2204
15. Goodman SI, Markey SP, Moe PG, Miles BS, Teng CC (1975) Glutaric aciduria: a "new" disorder of amino acid metabolism. Biochem Med 12:12-21
16. Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG (1977) Glutaric aciduria: Biochemical and morphologic considerations. J Pediatr 90:746-750
17. Gregersen N, Brandt NJ (1979) Ketotic episodes in glutaryl-CoA dehydrogenase deficiency (glutaric aciduria). Pediatr Res 13:977-981
18. Hillered L, Ernster L (1983) Respiratory activity of isolated rat brain mitochondria following in vitro exposure to oxygen radicals. J Cereb Blood Flow Metab 3:207-214
19. Hoffmann GF, Zchoscke J (1999) Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Meatb Dis 22:381-391
20. Hughes BP (1962) A method for the estimation of serum CK and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7:597-603
21. Koeller DM, Woontner M, Crnic LS, Kleinschmidt-DeMasters B, Stephens J, Hunt EL, Goodman SI (2002) Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11:347-357
22. Kölker S, Garbade SF, Greenberg CR, Leonard JV, Saudubray JM, Ribes A, Kalkanoglu HS, Lund AM, Merinero B, Wajner M, Troncoso M, Williams M, Walter JH, Campistol J, Marti-Herrero M, Caswill M, Burlina AB, Lagler F, Maier EM, Schwahn B, Tokatli A, Dursun A, Coskun T, Chalmers RA, Koeller DM, Zschocke J, Christensen E, Burgard P, Hoffmann GF (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59:840-847
23. Kölker S, Ahlemeyer B, Huhne R, Mayatepek E, Krieglstein J, Hoffmann GF (2001b) Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures. Eur J Neurosci 13:2115-2122
24. Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (1999) 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis 22:259-262
25. Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2001a) Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 50:76-82
26. Kölker S, Hoffmann GF, Schor DS, Feyh P, Wagner L, Jeffrey I, Pourfarzam M, Okun JG, Zschocke J, Baric I, Bain MD, Jakobs C, Chalmers RA (2003) Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics 34:253-260
27. Kölker S, Okun JG, Ahlemeyer B, Wyse AT, Horster F, Wajner M, Kohlmuller D, Mayatepek E, Krieglstein J, Hoffmann GF (2002) Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J Neurosci Res 68:424-431
28. Külkens S, Harting I, Sauer S, Zschocke J, Hoffmann GF, Gruber S, Bodamer OA, Kölker S (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64:2142-2144
29. Latini A, Borba Rosa R, Scussiato K, Llesuy S, Bello-Klein A, Wajner M (2002) 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res 956:367-373
30. Latini A, Scussiato K, Leipnitz G, Dutra-Filho CS, Wajner M (2005) Promotion of oxidative stress by 3-hydroxyglutaric acid in rat striatum. J Inherit Metab Dis 28:57-67
31. Lima TT, Begnini J, de Bastiani J, Fialho DB, Jurach A, Ribeiro MC, Wajner M, de Mello CF (1998) Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Res 802:55-60
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
33. Lund TM, Christensen E, Kristensen AS, Schousboe A, Lund AM (2004) On the neurotoxicity of glutaric, 3-hydroxyglutaric, and trans-glutaconic acids in glutaric acidemia type I. J Neurosci Res 77:143-147
34. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, Wallace DC (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 96:846-851
35. Mordekar SR, Guthrie P, Bonham JR, Olpin SE, Hargreaves I, Baxter PS (2006) The significance of reduced respiratory chain enzyme activities: Clinical, biochemical and radiological associations. Eur J Paediatr Neurol 10:78-82
36. Nagy ZS, Esiri MM, LeGris M, Matthews PM (1999) Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology. Acta Neuropathol 97:346-354
37. 3H]glutamate binding to plasma membranes from brain of young rats by glutaric acid in vitro. J Neurol Sci 73:93-96
38. Rafique R, Schapira AH, Cooper JM (2001) Sensitivity of respiratory chain activities to lipid peroxidation: Effect of vitamin E deficiency. Biochem J 357:887-892
39. Rosa RB, Schwarzbold C, Dalcin KB, Ghisleni GC, Ribeiro CA, Moretto MB, Frizzo ME, Hoffmann GF, Souza DO, Wajner M (2004) Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats. Neurochem Int 45:1087-1094
40. Rustin P, Chretien D, Bourgeron T, Gérard B, Rötig A, Saudubray JM, Munnich A (1994) Biochemical and Molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35-51
41. Sauer SW, Okun JG, Fricker G, Mahringer A, Muller I, Crnic LR, Muhlhausen C, Hoffmann GF, Horster F, Goodman SI, Harding CO, Koeller DM, Kolker S (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97:899-910
42. Sauer SW, Okun JG, Schwab MA, Crnic LR, Hoffmann GF, Goodman SI, Koeller DM, Kölker S (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 280:830-836
43. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55:2142-2145
44. Schuck PF, Leipnitz G, Ribeiro CA, Dalcin KB, Assis DR, Barschak AG, Pulrolnik V, Wannmacher CM, Wyse AT, Wajner M (2002) Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats. Neurochem Res 27:1633-1639
45. Silva CG, Silva AR, Ruschel C, Helegda C, Wyse AT, Wannmacher CM, Dutra-Filho CS, Wajner M (2000) Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats. Metab Brain Dis 15:123-131
46. Strauss KA, Morton DH (2003) Type I glutaric aciduria, part 2: A model of acute striatal necrosis. Am J Med Genet 121:53-70
47. Strazielle C, Sturchler-Pierrat C, Staufenbiel M, Lalonde R (2003) Regional brain cytochrome oxidase activity in b-amyloid precursor protein transgenic mice with the Swedish mutation. Neuroscience 118:1151-1163
48. Ullrich K, Flott-Rahmel B, Schluff P, Musshoff U, Das A, Lucke T, Steinfeld R, Christensen E, Jakobs C, Ludolph A, Neu A, Roper R (1999) Glutaric aciduria type I: Pathomechanisms of neurodegeneration. J Inherit Metab Dis 22:392-403
49. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 265:16330-16336